Kampala: The Ebola outbreak in Africa has seen a significant escalation, with the death toll reaching 89 in just one week, according to Dr. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention (Africa CDC). The situation has raised concerns over the capacity of treatment facilities and the increasing rate of community transmission.
According to News Agency of Nigeria, Dr. Kaseya addressed these concerns during an online media briefing, highlighting that treatment centers are currently operating at 95 percent bed occupancy. The urgent need for expanded treatment facilities and early case detection was emphasized to mitigate the number of patients requiring hospital admission. He identified Bunia, Gwampara, Mugwalu, and Nyankunde as the main hotspots, while South Kivu has not reported new cases, pending confirmation of this trend.
The outbreak has been notably severe in five health zones in Ituri and one in North Kivu, accounting for more than 85 percent of reported cases. Uganda has recorded a total of 19 cases, with recent infections linked to contacts from the Democratic Republic of Congo (DRC). Active contact monitoring remains crucial, with only 77 percent of contacts currently being monitored daily.
Efforts are underway to enhance contact tracing and community response, including plans to deploy 20,000 local youths for this purpose. Dr. Kaseya warned that the outbreak has grown 3.6 times larger than past outbreaks in Uganda and West Africa, and could become the largest on record if not controlled.
International efforts are being made to curb the spread, including travel restrictions for individuals flying from Ituri to Kinshasa and substantial financial pledges, though only a fraction of the promised funds have been released. Humanitarian needs have increased the required budget to 1.4 billion dollars, highlighting the long-term cost implications if the outbreak is not contained.
In terms of medical response, the DRC has received antiviral treatments, and clinical trials for post-exposure prophylaxis are set to begin. Four candidate vaccines are also under consideration, with hopes of availability before year-end. Africa CDC is spearheading laboratory responses, providing diagnostic machines and testing cartridges across affected regions, and implementing digital systems for cross-border data sharing.
Weekly updates on the outbreak and ongoing developments in therapeutics and vaccine research will continue to be provided to the media and the public.